Cargando…

FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study

BACKGROUND: Fluoro-L-thymidine (FLT) is a positron emission tomography/computed tomography (PET/CT) tracer which reflects proliferative activity in a cancer lesion. The main objective of this prospective explorative study was to evaluate whether FLT-PET can be used for the early evaluation of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mogensen, Marie Benzon, Loft, Annika, Aznar, Marianne, Axelsen, Thomas, Vainer, Ben, Osterlind, Kell, Kjaer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503853/ https://www.ncbi.nlm.nih.gov/pubmed/28695424 http://dx.doi.org/10.1186/s13550-017-0302-3

Ejemplares similares

Dynamic Contrast-Enhanced Ultrasound of Colorectal Liver Metastases as an Imaging Modality for Early Response Prediction to Chemotherapy
por: Mogensen, Marie Benzon, et al.
Publicado: (2017)

Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases
por: Eefsen, Rikke Løvendahl, et al.
Publicado: (2012)

HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
por: Knudsen, Andreas, et al.
Publicado: (2014)

Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing
por: Mogensen, M. B., et al.
Publicado: (2018)

Tissue inhibitor of matrix metalloproteinase‐1 expression in colorectal cancer liver metastases is associated with vascular structures
por: Illemann, Martin, et al.
Publicado: (2015)

PET/MR imaging of sarcomas: effect of PET quantification by classification of tissue
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2014)

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study
por: Fosbøl, Marie Øbro, et al.
Publicado: (2021)

Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases
por: Heskamp, Sandra, et al.
Publicado: (2016)

FLT PET-CT in evaluation of treatment response
por: Sanghera, Bal, et al.
Publicado: (2014)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial
por: Lawaetz, Mads, et al.
Publicado: (2023)

Identification and characterization of human brown adipose tissue (BAT) content and metabolism in adults using [(18)F]-FDG PET/MR – a pilot study
por: Johannesen, Helle H, et al.
Publicado: (2014)

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients
por: Risør, Louise Madeleine, et al.
Publicado: (2022)

Colorectal Liver Metastases
por: Haddad, Ashraf J., et al.
Publicado: (2011)

PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
por: Dueland, Svein, et al.
Publicado: (2022)

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients
por: Risør, Louise Madeleine, et al.
Publicado: (2023)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020)

Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET
por: Munk Jensen, Mette, et al.
Publicado: (2013)

Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010)

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases
por: Nielsen, Karin, et al.
Publicado: (2014)

Surgery for colorectal liver metastases
por: Primrose, J N
Publicado: (2010)

Treatment of colorectal liver metastases
por: Ismaili, Nabil
Publicado: (2011)

Critical considerations for targeting colorectal liver metastases with nanotechnology
por: Arshad, Usman, et al.
Publicado: (2019)

Initial Experience with (64)Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
por: Loft, Mathias, et al.
Publicado: (2021)

KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver
por: Popovic, M., et al.
Publicado: (2020)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

An Uncommon Case of Pediatric Esthesioneuroblastoma Presenting as SIADH: (18)F-FDG PET/CT in Staging and Post-Therapeutic Assessment
por: Fosbøl, Marie Øbro, et al.
Publicado: (2018)

Correction: Christensen et al. Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics 2021, 11, 279
por: Christensen, Tine N., et al.
Publicado: (2022)

Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
por: DANIŞAN, Gürkan, et al.
Publicado: (2022)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

Early Detection of Response to Experimental Chemotherapeutic Top216 with [(18)F]FLT and [(18)F]FDG PET in Human Ovary Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2010)

[18F]FLT PET for Non-Invasive Assessment of Tumor Sensitivity to Chemotherapy: Studies with Experimental Chemotherapy TP202377 in Human Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2012)

The blood supply of colorectal liver metastases.
por: Taylor, I., et al.
Publicado: (1978)

Treatment of Non-Colorectal Liver Metastases
por: Frilling, Andrea, et al.
Publicado: (2015)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

Macrophages in Colorectal Cancer Liver Metastases
por: Cortese, Nina, et al.
Publicado: (2019)

Colorectal liver metastases: radiopathological correlation
por: Paulatto, Luisa, et al.
Publicado: (2020)

THE ERA OF MANAGEMENT OF COLORECTAL LIVER METASTASES
por: Martel, Gareth, et al.
Publicado: (2020)

Colorectal Cancer, Liver Metastases and Biotherapies
por: Osei-Bordom, Daniel-Clement, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkpjdj23l89qb0ggrqfvfvq2fs